WUHAN, CHINA - JANUARY 22: (CHINA OUT) Security personnel check the temperature of passengers in the Wharf at the Yangtze River on January 22, 2020 in Wuhan, Hubei province, China. A new infectious coronavirus known as "2019-nCoV" was discovered in Wuhan as the number of cases rose to over 400 in mainland China.
The outcomes of clinical trials conducted by medical authorities in China suggest that a drug used in Japan to treat new strands of the influenza appears to be effective in coronavirus patients.
Zhang Xinmin, an official at China’s science and technology ministry, told reporters on Tuesday that the drug favipiravir has “a high degree of safety and is clearly effective in treatment.”
Patients who were given the medicine during trials turned negative after an average of four days after contracting the virus. In comparison, those who were not treated with the drug turned negative after an average of 11 days.
Researchers also found that the lung condition of patients improved about 91% of the patients who were given the drug, compared to 62% of patients who did not take it.
Results of the trials suggest that the drug is not effective in treating patients with more severe symptoms of the virus.
The trials involved 340 patients in total.
Fujifilm Toyama Chemical, which developed favipiravir in 2014, has declined to comment.
Singer Dua Lipa is prepping for her 2025 show dates for her Radical Optimism tour.…
https://youtu.be/tail2x6qkAs President Joe Biden awarded the Medal of Freedom to 19 recipients at a ceremony in Washington…
Golden Globe Awards' new owner, the investment firm Eldridge Industries, and former owner, Hollywood Foreign…
Pop queen Madonna posted a photo on Instagram with her boyfriend, former soccer player Akeem…
Filmmaker Jeff Baena, The White Lotus star Aubrey Plaza's husband, was found dead at 47…
Adrian Peterson, the former Minnesota Vikings running back, is once again facing legal troubles. Despite…